rechallenge with egfr inhibitors in ctdna ras/braf wt refractory mcrc
Published 9 months ago • 56 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
6:36
detecting resistance to egfr rechallenge in ras/raf wt crc
-
9:56
how does braf rechallenge and retreatment impact tumor histology beyond melanoma?
-
4:27
chronos trial: anti-egfr rechallenge therapy with panitumumab driven by ctdna molecular selectio...
-
3:51
combining braf, mek and egfr inhibition in mcrc
-
1:44
cxcr1/2 and pd-1 inhibition in ctdna positive and ras-mutant crc
-
1:33
acquired resistance to anti-egfr therapy in colorectal cancer
-
1:26
the challenge of treatment resistance in patients with advanced egfr-mutated nsclc
-
1:04
molecular testing in egfr mutant driven nsclc
-
0:58
real-world monitoring of circulating tumor dna to predict cancer recurrence
-
0:51
what the future may hold for ctdna in cancer screening and diagnosis
-
2:29
independent prognostic value of total metabolic tumor volume in advanced-stage fl
-
2:09
further: firmonertinib in nsclc with egfr pacc mutations
-
2:05
assess trial: blood test for egfr mutation in advanced non-small cell lung cancer
-
6:01
how to know when a re-biopsy is necessary for an advanced nsclc patient?
-
0:55
molecular testing for the evaluation of colorectal cancer
-
3:50
mechanisms of resistance to efgr antibodies in mcrc
-
0:49
dr. bendell on remaining questions with regorafenib in hcc
-
3:36
outcomes of patients with newly diagnosed crlf2-rearranged b-all
-
0:58
what is the current state of genomic testing in metastatic colorectal cancer?